Genetic and tissue analysis reveals new targets for lymphatic malformations

Lymphatic malformations are rare disorders in which lymph vessels develop abnormally, often beginning in childhood and sometimes causing swelling, infection, bleeding, pain, or airway obstruction. Researchers led by the University of Osaka have combined genetic analysis with detailed examination of patient tissues to uncover common features of the disease and identify molecular clues that could inform future treatment strategies.

The team analyzed tissue samples from 34 patients. Changes in the PIK3CA gene, which are known to contribute to abnormal lymphatic vessel growth, were detected in 20 patients, or 58.8%. Most clinical features were similar whether a mutation was detected, but malformed vessels showed a more scattered growth pattern in patients carrying PIK3CA mutations.

The researchers also found that a major cell-growth signaling system, the PI3K/AKT/mTOR pathway, was more active in malformed lymphatic vessels than in normal vessels regardless of PIK3CA mutation status. AKT activity also increased with patient age. These findings are consistent with the clinical effectiveness of sirolimus, a drug that targets this pathway, across patients with lymphatic malformations.

To search for additional disease-related molecules, the team performed spatial transcriptomic analysis in two PIK3CA-mutant cases. Ten genes were commonly more active in malformed lymphatic vessels. Among them, NFATC1 was strongly expressed in the endothelial cells lining malformed lymphatic vessels. The findings suggest that the calcineurin-NFAT pathway may also contribute to the disease pathogenesis and could represent a future therapeutic target.

We succeeded in providing a more integrated view of lymphatic malformations, from genetic changes to pathological morphology and molecular activity. We hope that this may help refine existing treatments while guiding the search for new ones."

Katsutoshi Hirose, first author, The University of Osaka Graduate School of Dentistry

 

Source:
Journal reference:

Hirose, K., et al. (2026). Comprehensive Molecular and Clinicopathological Profiling of Lymphatic Malformations. Laboratory Investigation. DOI: 10.1016/j.labinv.2026.106168. https://www.laboratoryinvestigation.org/article/S0023-6837(26)00098-X/fulltext

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NIH awards $7.6 million grant to advance polyaminopathy research